Terms: = Ovarian cancer AND SND1, Q7KZF4, TDRD11, p100, ENSG00000197157, 27044
12 results:
1. Prognostic value of ALK overexpression and molecular abnormalities in high-grade serous ovarian carcinoma.
Gorczyński A; Miszewski K; Gager Y; Koch S; Pötschke J; Ugrinovski D; Gabert J; Pospieszyńska A; Wydra D; Duchnowska R; Szymanowski B; Cierniak S; Kruecken I; Neumann K; Mirkov K; Biernat W; Czapiewski P
Cancer Biomark; 2023; 38(1):17-26. PubMed ID: 37522200
[TBL] [Abstract] [Full Text] [Related]
2. Proteomic Discovery of Plasma Protein Biomarkers and Development of Models Predicting Prognosis of High-Grade Serous ovarian Carcinoma.
Kim SI; Hwangbo S; Dan K; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Han D; Lee M
Mol Cell Proteomics; 2023 Mar; 22(3):100502. PubMed ID: 36669591
[TBL] [Abstract] [Full Text] [Related]
3. snd1 confers chemoresistance to cisplatin-induced apoptosis by targeting GAS6-AKT in SKOV3 ovarian cancer cells.
Ha C; Hu L; Ren Y; Yang J; Xin L
Med Oncol; 2022 Aug; 39(11):169. PubMed ID: 35972612
[TBL] [Abstract] [Full Text] [Related]
4. miR-1224-5p inhibits the proliferation and invasion of ovarian cancer via targeting snd1.
Wang J; Hu Y; Ye C; Liu J
Hum Cell; 2020 Jul; 33(3):780-789. PubMed ID: 32409958
[TBL] [Abstract] [Full Text] [Related]
5. snd1 acts upstream of SLUG to regulate the epithelial-mesenchymal transition (EMT) in SKOV3 cells.
Xin L; Zhao R; Lei J; Song J; Yu L; Gao R; Ha C; Ren Y; Liu X; Liu Y; Yao Z; Yang J
FASEB J; 2019 Mar; 33(3):3795-3806. PubMed ID: 30509125
[TBL] [Abstract] [Full Text] [Related]
6. Role of metadherin in estrogen-regulated gene expression.
Li Y; Gonzalez Bosquet J; Yang S; Thiel KW; Zhang Y; Liu H; Leslie KK; Meng X
Int J Mol Med; 2017 Aug; 40(2):303-310. PubMed ID: 28627585
[TBL] [Abstract] [Full Text] [Related]
7. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration.
Permuth JB; Reid B; Earp M; Chen YA; Monteiro AN; Chen Z; ; Chenevix-Trench G; Fasching PA; Beckmann MW; Lambrechts D; Vanderstichele A; Van Niewenhuyse E; Vergote I; Rossing MA; Doherty JA; Chang-Claude J; Moysich K; Odunsi K; Goodman MT; Shvetsov YB; Wilkens LR; Thompson PJ; Dörk T; Bogdanova N; Butzow R; Nevanlinna H; Pelttari L; Leminen A; Modugno F; Edwards RP; Ness RB; Kelley J; Heitz F; Karlan B; Lester J; Kjaer SK; Jensen A; Giles G; Hildebrandt M; Liang D; Lu KH; Wu X; Levine DA; Bisogna M; Berchuck A; Cramer DW; Terry KL; Tworoger SS; Poole EM; Bandera EV; Fridley B; Cunningham J; Winham SJ; Olson SH; Orlow I; Bjorge L; Kiemeney LA; Massuger L; Pejovic T; Moffitt M; Le N; Cook LS; Brooks-Wilson A; Kelemen LE; Gronwald J; Lubinski J; Wentzensen N; Brinton LA; Lissowska J; Yang H; Hogdall E; Hogdall C; Lundvall L; Pharoah PD; Song H; Campbell I; Eccles D; McNeish I; Whittemore A; McGuire V; Sieh W; Rothstein J; Phelan CM; Risch H; Narod S; McLaughlin J; Anton-Culver H; Ziogas A; Menon U; Gayther S; Ramus SJ; Gentry-Maharaj A; Pearce CL; Wu AH; Kupryjanczyk J; Dansonka-Mieszkowska A; Schildkraut JM; Cheng JQ; Goode EL; Sellers TA
Oncotarget; 2016 Nov; 7(45):72381-72394. PubMed ID: 27911851
[TBL] [Abstract] [Full Text] [Related]
8. Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer.
Yakubov B; Chelladurai B; Schmitt J; Emerson R; Turchi JJ; Matei D
Neoplasia; 2013 Jun; 15(6):609-19. PubMed ID: 23730209
[TBL] [Abstract] [Full Text] [Related]
9. Atypical paraneoplastic syndrome associated with anti-Yo antibodies.
Finsterer J; Bodenteich A; Drlicek M
Clin Neuropathol; 2003; 22(3):137-40. PubMed ID: 12809356
[TBL] [Abstract] [Full Text] [Related]
10. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter.
Chai YL; Cui J; Shao N; Shyam E; Reddy P; Rao VN
Oncogene; 1999 Jan; 18(1):263-8. PubMed ID: 9926942
[TBL] [Abstract] [Full Text] [Related]
11. Differential transcriptional activation by the N-terminal region of BRCA1 splice variants BRCA1a and BRCA1b.
Cui JQ; Wang H; Reddy ES; Rao VN
Oncol Rep; 1998; 5(3):585-9. PubMed ID: 9538156
[TBL] [Abstract] [Full Text] [Related]
12. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN
Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350
[TBL] [Abstract] [Full Text] [Related]
